PlainRecalls
FDA Drug Moderate Class II Terminated

Tarceva (erlotinib) Tablets, 150 mg, 30 count bottle, Rx only, Manufactured by: Kremers Urban Pharmaceuticals Inc. Seymour, IN 47274 NDC 50242-064-01

Reported: October 15, 2014 Initiated: September 15, 2014 #D-0008-2015

Product Description

Tarceva (erlotinib) Tablets, 150 mg, 30 count bottle, Rx only, Manufactured by: Kremers Urban Pharmaceuticals Inc. Seymour, IN 47274 NDC 50242-064-01

Reason for Recall

Failed Dissolution Specifications: The product did not meet the acceptance criteria for the dissolution test during the 24 month routine stability testing.

Details

Recalling Firm
Astellas Pharma US Inc
Units Affected
9,236 bottles
Distribution
Nationwide
Location
Northbrook, IL

Frequently Asked Questions

What product was recalled?
Tarceva (erlotinib) Tablets, 150 mg, 30 count bottle, Rx only, Manufactured by: Kremers Urban Pharmaceuticals Inc. Seymour, IN 47274 NDC 50242-064-01. Recalled by Astellas Pharma US Inc. Units affected: 9,236 bottles.
Why was this product recalled?
Failed Dissolution Specifications: The product did not meet the acceptance criteria for the dissolution test during the 24 month routine stability testing.
Which agency issued this recall?
This recall was issued by the FDA Drug on October 15, 2014. Severity: Moderate. Recall number: D-0008-2015.